NCT00059735View on ClinicalTrials.gov

A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2002

Study Completion Date

December 31, 2003

Conditions
Kidney NeoplasmsCarcinoma, Renal CellAdenocarcinoma, Renal Cell
Interventions
DRUG

E7070

Trial Locations (5)

10021

New York

10032

New York

10466

The Bronx

94805

Villejuif

95817

Sacramento

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT00059735 - A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma | Biotech Hunter | Biotech Hunter